Company Updates covers news from Brilliant Blue Biosciences. Research & Industry News highlights relevant developments published by external sources, summarised and attributed to them.
A rare genetic mutation may protect against developing Parkinson's disease and Lewy body dementia, a new study from researchers at Oregon Health & Science University suggests.
By combining an antioxidant nanomaterial with a chemokine-binding cell membrane, researchers have reduced tumor development in mouse models of colitis-associated cancer.
Source: Nanowerk
Read more →The European Innovation Council (EIC) is providing approximately €3.8 million in funding for the international research project ADVANCE, in which Universitätsmedizin Frankfurt is participating. The ADVANCE research team aims to develop an mRNA-based cancer vaccine for the treatment of hepatocellular carcinoma (HCC).
Source: News-Medical
Read more →VectorY Therapeutics added €74.5 million ($83.5 million) to its Series A to fund a gene therapy that makes antibodies in the brain. The biotech’s lead asset VTx-002 is in a
Source: Endpoints News
Read more →The result represents a scientific milestone and positions Beam to submit a first-of-its-kind FDA application as soon as the end of the year.
Source: BioPharma Dive
Read more →A company developing extracellular vesicle-based products has developed a potency assay for quality control. They hope to adapt it for future products and scale it to commercial manufacturing.
Source: GEN — Genetic Engineering & Biotechnology News
Read more →Endosomal escape, cardiolipin affinity and surface charge: what two recent liposome studies found when SS-31 was used as a targeting ligand, and what to verify about an SS-31 peptide for research before building a formulation.
Source: Nanowerk
Read more →For years, gene therapy researchers debated whether the viruses they use to ferry replacement genes into cells could cause tumors. A small number of cases now offer strong evidence that…
Source: STAT
Read more →Tiny spiked particles mixed into creams create microscopic openings in the skin, increasing delivery of a tested skincare compound nearly 37-fold without requiring injections or patches.
Source: Nanowerk
Read more →Reported by Nature. Follow the link to read the original article.
Source: Nature
Read more →A new review was published in Volume 13 of Oncoscience on September 30, 2026, titled "Extracellular vesicles in health, aging and disease."
Source: News-Medical
Read more →"Two cases to date have shown evidence of vector integration into the DNA of the patients. In both cases, the patients underwent treatment and continue to be monitored,” Novartis said in a statement.
Source: GEN — Genetic Engineering & Biotechnology News
Read more →We co-develop nanocarrier and biosensing programmes with pharma, biotech and academic groups — from target selection through scale-up.
